Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Sangamo Therapeutics Inc SGMO

Healthcare Biotechnology
Sangamo Therapeutics, Inc. is a genomic medicines company that is developing medicines for neurological diseases. The Company's neurology preclinical development is focused on two areas: development of epigenetic regulation therapies to treat serious neurological diseases, and development of novel engineered adeno-associated virus (AAV) capsids to deliver its therapies to the intended... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SGMO)

Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results

Business Wire 12 days ago

Sangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editing

Business Wire 12 days ago

Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast

Business Wire May 2, 2024

Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Business Wire April 22, 2024

Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering

Business Wire March 22, 2024

Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

Business Wire March 13, 2024

Sangamo Therapeutics Announces Data From Novel Proprietary Neurotropic AAV Capsid Demonstrating Industry-leading Blood-brain Barrier Penetration and Brain Transduction in NHPs

Business Wire March 13, 2024

Sangamo Therapeutics Announces Fourth Quarter and Full Year 2023 Conference Call and Webcast

Business Wire March 12, 2024

Sangamo Therapeutics Announces U.S. FDA Alignment on Abbreviated Pathway to Potential Approval and EMA Prime Eligibility for ST-920 in Fabry Disease

Business Wire February 12, 2024
View More News ››

Opinion & Analysis (NDAQ:SGMO)

Sangamo Shares Trade 30% Higher on Q4 Earnings and Biogen Collaboration

Streetwise Reports March 2, 2020

Sangamo and Pfizer Report Positive Results for Hemophilia A Study

Streetwise Reports July 9, 2019

Investment in cell and gene therapies ramps up

The Life Sciences Report June 8, 2016

Big money to be made in biotech stocks

Andrew Mickey December 1, 2008
View More Opinion ››

Bullboard Posts (NDAQ:SGMO)

Sangamo Therapeutics Announces U.S. FDA Alignment on Abbrevi

BREAKING NEWS: $SGMO Sangamo Therapeutics Announces U.S. FDA Alignment on Abbreviated Pathway to Potential Approval and EMA Prime...
whytestocks - February 12, 2024

3 BIOTECH STOCKS INSIDERS ARE SELLING

3 BIOTECH STOCKS INSIDERS ARE SELLING $VERU $FBIO $SGMO Learn More https://www.aviseanalytics.com/3-biotech-stocks-insiders-are...
AviseAnalytics - August 26, 2021

Seeking Alpha got a sell on this stock

? how low will it go
Danalo - April 12, 2012

The Truth about "Z Finger Technique"

The Truth about "Z Finger Technique" We Expose a Website's Hype - Just the Facts, Ma'am May 26, 2006 – A...
scissors14 - June 12, 2006
View more Bullboard ››

Permex Petroleum Corp

Permex Petroleum Corp

Permex Petroleum Corporation is a junior oil and gas company. The Company is engaged in the acquisition, exploration ...
View More »